The GRAS acceptance follows on heels of recent FDA acknowledgement of a new dietary ingredient (NDI) notification for Superba krill oil.
FDA has accepted, with no objections, a self-affirmed Generally Recognized as Safe (GRAS) notification for Aker BioMarine’s (Oslo, Norway) Superba krill oil. As such, Superba krill oil is now deemed safe for use in food and beverage.
The GRAS acceptance follows on heels of recent FDA acknowledgement of a new dietary ingredient (NDI) notification for Superba krill oil.
Matts Johansen, the company’s executive vice president of sales and marketing, stated, “…Aker BioMarine Antarctic has developed an extensive safety dossier for Superba krill oil. The FDA’s earlier acknowledgement of our NDI notification was important for our existing and future customers to introduce Superba products in all supplement channels, while the new self-affirmed GRAS notice acceptance solidly opens the door to applications in the food and beverage industries as well.”
The phospholipid-bound eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in Superba krill oil are said to be highly bioavailable. The company says it is now actively exploring functional food applications in the United States.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.